Bladder Cancer
Gene Signatures Predicting Recurrence and Progression of Bladder Cancer - Expert Commentary
April 19, 2022
Molecular Subtypes as a Basis for Stratified Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer-A Narrative Review.
April 19, 2022
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancer.
April 15, 2022
Highly Sensitive and Specific Detection of Bladder Cancer via Targeted Ultra-deep Sequencing of Urinary DNA.
April 14, 2022
Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.
April 13, 2022